Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/371
Title: Endothelial dysfunction in patients with ankylosing spondylitis after covid-19
Authors: Rakhimova M., Akhmedov Kh., Rakhimova O.
Keywords: ankylosing spondylitis, COVID-19, endo- thelial dysfunction.
Issue Date: 2024
Citation: Toshkent
Series/Report no.: UDK;616-008:616.13-02:612.017.1-616-074-08
Abstract: Study of endothelial dysfunction against the background of systemic inflammation in patients with an- kylosing spondylitis who have had COVID-19. Material and methods: The study included 80 patients diagnosed with ankylosing spondylitis according to the modified New York criteria and EULAR. All patients were divided into 2 groups: 1st group - 40 patients with ankylosing spondylitis without a post-Covid period, 2nd - 40 patients with ankylosing spon- dylitis and a post-COVID period. The control group consist- ed of 40 healthy people with no history of acute or chronic diseases. Results: In patients with ankylosing spondylitis, survivors of COVID-19 and healthy people, there was no significant correlation between gender, age, serum lipids, smoking habit, C-reactive protein level and disease activity, although for some of of these variables, this may have oc- curred due to the small number of subjects included in the study. Conclusions: The lack of correlation between FMD indicators and disease activity should be confirmed by fur- ther studies with a larger number of subjects.
URI: http://repo.tma.uz/xmlui/handle/1/371
ISSN: 2181-7812
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
8. Akhmedov Kh., Rakhimova M.,.pdfEndothelial dysfunction in patients with ankylosing spondylitis after covid-19688.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.